STOCK TITAN

James Hardie director granted 748 shares

A James Hardie non-executive director received a routine share grant under the company’s compensation program, modestly increasing her direct holdings.

(Neutral)
(Neutral)
Form Type
4

Rhea-AI Filing Summary

James Hardie Industries plc (symbol: JHX) is the issuer of record for a Form 4 filing submitted to the SEC. Rowland Suzanne B reported acquisition or exercise transactions in this Form 4 filing.

James Hardie Industries plc (JHX) reported that director Suzanne B. Rowland received a grant of 748 ordinary shares on September 15, 2026, issued under the company’s Non-Executive Director Compensation Program. Following this award, she directly holds 17,049 ordinary shares of the company.

Positive

  • None.

Negative

  • None.
Insider Rowland Suzanne B
Role Director
Type Security Shares Price Value
Grant/Award Ordinary shares F1 748 $0.00 $0.00
Holdings After Transaction: Ordinary shares — 17,049 shares (Direct)
Footnotes (1)
  1. F1. Shares issued pursuant to the issuer's Non-Executive Director Compensation Program
Shares granted 748 ordinary shares Director equity grant on September 15, 2026
Price per share for grant $0.00 per share Stated value for the September 15, 2026 share award
Shares held after transaction 17,049 ordinary shares Director’s direct holdings following the grant
Non-Executive Director Compensation Program financial
"Shares issued pursuant to the issuer's Non-Executive Director Compensation Program"
Ordinary shares financial
"Shares issued pursuant to the issuer's Non-Executive Director Compensation Program"
Ordinary shares are a type of ownership stake in a company, giving shareholders a right to participate in the company’s profits and decision-making through voting. They are similar to owning a piece of a business, and their value can rise or fall based on the company's performance. Investors buy ordinary shares to potentially earn dividends and benefit from the company's growth over time.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What transaction did James Hardie Industries (JHX) disclose for director Suzanne B. Rowland?

The company disclosed that Suzanne B. Rowland received a grant of 748 ordinary shares on September 15, 2026, issued under James Hardie’s Non-Executive Director Compensation Program, as part of her board compensation rather than an open-market purchase.

How many James Hardie (JHX) shares does Suzanne B. Rowland hold after this grant?

After the reported grant, Suzanne B. Rowland directly holds 17,049 ordinary shares of James Hardie Industries plc. This figure reflects her updated direct ownership position following the September 15, 2026 award.

Was cash paid for the James Hardie (JHX) shares granted to Suzanne B. Rowland?

No cash consideration was reported. The 748 ordinary shares were issued with a stated price of $0.00 per share, indicating a compensation-related award under the Non-Executive Director Compensation Program.

Is the James Hardie (JHX) director share grant part of a Rule 10b5-1 trading plan?

No. The filing indicates that the transactions were not made pursuant to a Rule 10b5-1 trading plan, meaning the grant is a scheduled compensation award rather than trading under a pre-arranged plan.

What compensation program was used for the James Hardie (JHX) director share grant?

The filing states that the 748 ordinary shares granted to Suzanne B. Rowland were issued under James Hardie’s Non-Executive Director Compensation Program, which governs equity awards to non-executive members of the board.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Rowland Suzanne B

(Last)(First)(Middle)
303 E. WACKER DR.
STE. 2500

(Street)
CHICAGO ILLINOIS 60601

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
James Hardie Industries plc [ JHX ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
09/15/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Ordinary shares09/15/2026A748(1)A$017,049D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Shares issued pursuant to the issuer's Non-Executive Director Compensation Program
Remarks:
/s/ Aoife Rockett, as attorney-in-fact for Suzanne B. Rowland09/17/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Keep reading